89bio, Inc.
ETNB
$9.04
$0.273.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -111.50M | -71.28M | -118.35M | -149.07M | -47.97M |
| Total Depreciation and Amortization | 8.00K | 10.00K | 9.00K | 8.00K | 12.00K |
| Total Amortization of Deferred Charges | 318.00K | 455.00K | 326.00K | 175.00K | 168.00K |
| Total Other Non-Cash Items | 4.85M | 5.26M | 3.34M | 4.35M | 2.87M |
| Change in Net Operating Assets | 5.91M | -6.19M | -6.90M | -822.00K | -16.25M |
| Cash from Operations | -100.43M | -71.74M | -121.58M | -145.36M | -61.16M |
| Capital Expenditure | 0.00 | -72.00K | -15.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.62M | -7.76M | 19.84M | -8.64M | 27.85M |
| Cash from Investing | -106.62M | -7.83M | 19.82M | -8.64M | 27.85M |
| Total Debt Issued | -- | -- | 0.00 | 9.35M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.30M | 269.94M | 136.56M | 24.75M | 27.86M |
| Repurchase of Common Stock | -568.00K | -1.03M | -18.00K | -904.00K | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -137.00K | 0.00 | 137.00K |
| Cash from Financing | 20.73M | 268.91M | 136.41M | 33.19M | 27.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.32M | 189.34M | 34.65M | -120.81M | -5.36M |